Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Research Shows Laparoscopic and Open Gastrectomy Outcomes Are Similar

By HospiMedica International staff writers
Posted on 25 Feb 2019
Patients with gastric cancer who undergo laparoscopic distal gastrectomy have long-term survival rates comparable to those who undergo open gastrectomy, according to a new study.

Researchers at Seoul National University Bundang Hospital (Seongnam, South Korea), Yonsei University College of Medicine (Seoul, South Korea), and 11 other institutions in Korea conducted a study involving 1,416 patients (mean age, 57.3 years; 66.4% male) with stage I gastric cancer to examine if the surgical approach affected long-term survival. More...
Participants were randomly assigned to laparoscopic distal gastrectomy (705 patients) or open distal gastrectomy (711 patients). The main outcome was the difference in five year overall survival between the two groups.

The resulted showed five year overall survival rates were 94.2% in the laparoscopic group and 93.3% in the open surgery group; cancer-specific survival was also similar, at 97.1% and 97.2%, respectively. An intention-to-treat analysis confirmed the non-inferiority of the laparoscopic approach to the open approach. During the course of the study, 85 patients received a surgical approach opposite the one to which they were randomized, but per-protocol analysis results remained consistent with those using the intention-to-treat analysis. The study was published on February 7, 2019, in JAMA Oncology.

“Laparoscopic distal gastrectomy is gaining popularity over open distal gastrectomy for gastric cancer because of better early postoperative outcomes. However, to our knowledge, no studies have proved if laparoscopic distal gastrectomy is oncologically equivalent to open distal gastrectomy,” concluded lead author Woo Jin Hyung, MD, of Yonsei University College of Medicine, and colleagues. “The trial revealed similar overall and cancer-specific survival rates between patients. Laparoscopic distal gastrectomy is an oncologically safe alternative to open surgery for stage I gastric cancer.”

Five layers of tissue make up the stomach wall – the mucosa, submucosa, muscle, connective tissue (subserosa), and serosa. Gastric cancer begins in the mucosa and spreads through the outer layers as it grows. Treatment options for stage I gastric cancer (as examined in the study) includes total or subtotal gastrectomy, followed by optional chemotherapy. Other modalities include radiation therapy, targeted therapy, and immunotherapy.

Related Links:
Seoul National University Bundang Hospital
Yonsei University College of Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.